tetrazolo[1,5-a]pyridine-5-carboxylic acid
![tetrazolo[1,5-a]pyridine-5-carboxylic acid price.](/CAS/GIF/7477-12-5.gif)
|
- $99 - $475
- Product name: tetrazolo[1,5-a]pyridine-5-carboxylic acid
- CAS: 7477-12-5
- MF: C6H4N4O2
- MW: 164.12
- EINECS:
- MDL Number:MFCD12198087
- Synonyms:5-tetrazolo[5,1-f]pyridinecarboxylic acid;tetrazolo[5,1-f]pyridine-5-carboxylic acid;[1,2,3,4]tetrazolo[5,1-f]pyridine-5-carboxylic acid;tetrazolo[1,5-a]pyridine-5-carboxylic acid;tetrazolo[1,5-a]pyridine-5-carboxylic acid(SALTDATA: FREE)
4 prices
Selected condition：
Brand
- AK Scientific
- ChemBridge Corporation
- Crysdot
- Matrix Scientific
Package
- 250mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number9141AE
- Product descriptionTetrazolo[1,5-a]pyridine-5-carboxylicacid
- Packaging500mg
- Price$475
- Updated2021-12-16
- Buy
- ManufacturerChemBridge Corporation
- Product numberBB-4039942
- Product descriptiontetrazolo[1,5-a]pyridine-5-carboxylicacid 95%
- Packaging250mg
- Price$99
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11063121
- Product descriptionTetrazolo[1,5-a]pyridine-5-carboxylicacid 95+%
- Packaging1g
- Price$371
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number062420
- Product descriptionTetrazolo[1,5-a]pyridine-5-carboxylic acid
- Packaging500mg
- Price$315
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 9141AE | Tetrazolo[1,5-a]pyridine-5-carboxylicacid | 500mg | $475 | 2021-12-16 | Buy |
| ChemBridge Corporation | BB-4039942 | tetrazolo[1,5-a]pyridine-5-carboxylicacid 95% | 250mg | $99 | 2021-12-16 | Buy |
| Crysdot | CD11063121 | Tetrazolo[1,5-a]pyridine-5-carboxylicacid 95+% | 1g | $371 | 2021-12-16 | Buy |
| Matrix Scientific | 062420 | Tetrazolo[1,5-a]pyridine-5-carboxylic acid | 500mg | $315 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|